Yes. Is it possible that AZ could develop a slow release formula and sell it in parallel. They couldn’t market it for this disease but it would be still available.
Or, is Peptron‘s slow release formula patented?
Questions to ask Tom in relation to recent announcement dated 27.09.2021, page-72
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.162M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 111160 | 8.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.5¢ | 8006 | 2 |
View Market Depth
| Last trade - 11.00am 04/10/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable